Paracrine bone-derived senescent secretome is associated with spatially patterned extracellular matrix remodeling and altered biomechanics in human brain organoids
Oct 2026· Stem Cells· Vol 44· 0 citations· 29 references
Medicine
TL;DR
The results suggest that chronic paracrine exposure to senescent osteocyte-derived secretome is associated with localized extracellular matrix-related remodeling and mechanical vulnerability in human brain tissue, providing insight into how peripheral cellular senescence may contribute to regional brain fragility during aging.
Abstract
Abstract Aging is increasingly recognized as a systemic process, yet the mechanisms by which signals from senescent peripheral cells accelerate brain aging remain poorly defined. Here, we used chronic exposure of human cerebral organoids to the secretome of senescent osteocytes to investigate how peripheral aging signals from bone reshape brain tissue architecture. We combined spatially resolved optical fiber-based interferometry nanoindentation with transcriptomic and immunofluorescence profiling, revealing distinct mechanical features across complementary measurements, including lower apparent modulus in intact organoids and spatially localized regions of elevated modulus in cryosectioned specimens. This spatially heterogeneous biomechanical remodeling was accompanied by upregulation of extracellular matrix (ECM), inflammatory, and senescence pathways, and suppression of neurodevelopmental and synaptic gene networks. Our results suggest that chronic paracrine exposure to senescent osteocyte-derived secretome is associated with localized extracellular matrix-related remodeling and mechanical vulnerability in human brain tissue, providing insight into how peripheral cellular senescence may contribute to regional brain fragility during aging. These pilot-scale findings were obtained using a single induced pluripotent stem cell line and a single conditioned-medium batch, with 1-6 experimental replicates per condition across assays; the mechanical analyses were exploratory.
The aging secretome should be viewed as an organizing framework whose individual pathways and relative contributions require further validation in human bone, and provides a common context for comparing pathway-specific interventions, such as activin type II receptor blockade and sclerostin inhibition, with broader app...
Han-Hong Fang, Xiang-Long Zhou, Yang Liu et al.· Frontiers in Endocrinology· 0 citations
This review synthesizes current evidence on endothelial EV cargo and discusses how aging remodels vesicle composition and function to drive vascular–bone uncoupling, and compares bioengineering strategies aimed at correcting senescence-associated cargo liabilities and improving translational readiness.
Jin-Xin Zhang, Xing-Chen Wei, Na Han· International Journal of Mol...· 0 citations
The immune-fibrotic axis functions as a vicious feedback loop where age-related chronic, low-grade systemic inflammation (inflammaging) drives maladaptive tissue repair and fibrosis, while senescent fibrotic cells in turn amplify systemic inflammation. In the aging heart, immune dysregulation and fibroblast activation...
Aleksandra Aljakna Khan, A. Sintou, Yue Zhao et al.· Aging Cell· 0 citations
Cardiovascular aging is accompanied by profound remodeling of the extracellular matrix (ECM). Growing evidence suggests that ECM not only acts as a structural scaffold but also actively regulates cell behavior and vascular homeostasis. During aging, the vascular ECM undergoes numerous molecular, architectural, and bioc...
This framework aims to move senescence-targeted treatment beyond broad senolysis and toward testable precision strategies for aging bone by operationalizing cell- and stage-resolved therapeutic windows.
Lan Zhang, Yao Yao, Jinxv Chen· Frontiers in Immunology· 0 citations
F fibro-inflammatory BM remodeling is established as a defining feature of clonal hematopoiesis of indeterminate potential, linking it to prefibrotic stromal changes and niche reorganization that may facilitate progression to overt malignancy.
Alicia G. Aguilar-Navarro, Gibran Edun, M. Gower et al.· Nature Immunology· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.